Setting Research Priorities for Kidney Cancer

Jennifer M Jones; Jaimin Bhatt; Jonathan Avery; Andreas Laupacis; Katherine Cowan; Naveen S Basappa; Joan Basiuk; Christina Canil; Sohaib Al-Asaaed; Daniel Y C Heng; Lori Wood; Dawn Stacey; Christian Kollmannsberger; Michael A S Jewett

doi:10.1016/j.eururo.2017.04.011

Setting Research Priorities for Kidney Cancer

Eur Urol. 2017 Dec;72(6):861-864. doi: 10.1016/j.eururo.2017.04.011. Epub 2017 May 8.

Authors

Affiliations

¹ Cancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre, University Health Network, and Department of Psychiatry, University of Toronto, Toronto, Canada. Electronic address: jennifer.jones@uhn.ca.
² Departments of Surgery and Surgical Oncology (Division of Urology), Princess Margaret Cancer Centre, University Health Network, and the University of Toronto, Toronto, Canada.
³ School of Rehabilitation Sciences, University of Ottawa, Ottawa, Canada.
⁴ Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Canada.
⁵ James Lind Alliance, Southampton, UK.
⁶ Cross Cancer Institute, Department of Oncology, University of Alberta, Edmonton, Canada.
⁷ Kidney Cancer Research Network of Canada.
⁸ Department of Internal Medicine, Division of Medical Oncology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Canada.
⁹ Division of Medical Oncology, Memorial University of Newfoundland, St. John's, Canada.
¹⁰ Department of Medical Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Canada.
¹¹ Division of Medical Oncology, Department of Urology, Dalhousie University, Halifax, Canada.
¹² Faculty of Health Sciences, School of Nursing and Ottawa Hospital Research Institute, Ottawa, Canada.
¹³ Medical Oncology, University of British Columbia and Medical Oncology BC Cancer Agency.

PMID: 28495043
DOI: 10.1016/j.eururo.2017.04.011

Abstract

Defining disease-specific research priorities in cancer can facilitate better allocation of limited resources. Involving patients and caregivers as well as expert clinicians in this process is of value. We undertook this approach for kidney cancer as an example. The Kidney Cancer Research Network of Canada sponsored a collaborative consensus-based priority-setting partnership that identified ten research priorities in the management of kidney cancer. These are discussed in the context of current initiatives and gaps in knowledge.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
Biomedical Research*
Biopsy
Decision Support Systems, Clinical
Health Services Accessibility
Humans
Kidney / pathology
Kidney Neoplasms / diagnosis
Kidney Neoplasms / pathology*
Kidney Neoplasms / therapy*
Risk Factors

Substances

Biomarkers

Grants and funding

138851/CIHR/Canada